Literature DB >> 14443204

Hyperuricaemia due to pyrazinamide.

J SCHNEEWEISS, G W POOLE.   

Abstract

Entities:  

Keywords:  PYRAZINAMIDE/toxicology; URIC ACID/blood

Mesh:

Substances:

Year:  1960        PMID: 14443204      PMCID: PMC2097774          DOI: 10.1136/bmj.2.5202.830

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  7 in total

1.  Hyperuricemia due to pyrazinamide.

Authors:  M SHAPIRO; L HYDE
Journal:  Am J Med       Date:  1957-10       Impact factor: 4.965

2.  The occurrence of hyperuricemia during pyrazinamide-isoniazid therapy.

Authors:  J H CULLEN; L J EARLY; J M FIORE
Journal:  Am Rev Tuberc       Date:  1956-08

3.  Experience with pyrazinamide.

Authors:  B P POTTER; S F CHANG
Journal:  Dis Chest       Date:  1955-01

4.  The chemotherapy of pulmonary tuberculosis with pyrazinamide used alone and in combination with streptomycin, para-aminosalicylic acid, or isoniazid.

Authors:  W S SCHWARTZ; R E MOYER
Journal:  Am Rev Tuberc       Date:  1954-09

5.  Pyrazinoic acid amide; an agent active against experimental murine tuberculosis.

Authors:  M SOLOTOROVSKY; F J GREGORY; E J IRONSON; E J BUGIE; R C O'NEILL; R PFISTER
Journal:  Proc Soc Exp Biol Med       Date:  1952-04

6.  Pyrazinamide (aldinamide) in the treatment of pulmonary tuberculosis.

Authors:  R L YEAGER; W G C MUNROE; F I DESSAU
Journal:  Am Rev Tuberc       Date:  1952-05

7.  Observations on the combined use of pyrazinamide (Aldinamide) and isoniazid in the treatment of pulmonary tuberculosis; a clinical study.

Authors:  M CAMPAGNA; A CALIX; G HAUSER
Journal:  Am Rev Tuberc       Date:  1954-03
  7 in total
  2 in total

1.  THE EPIDEMIOLOGY OF RHEUMATIC DISEASES.

Authors:  J H KELLGREN
Journal:  Ann Rheum Dis       Date:  1964-03       Impact factor: 19.103

2.  Gout and hyperuricaemia in rural and urban populations.

Authors:  A J POPERT; J V HEWITT
Journal:  Ann Rheum Dis       Date:  1962-06       Impact factor: 19.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.